GSK’s Nucala approved to treat chronic rhinosinusitis with nasal polyps

30th July 2021 Uncategorised 0

Nucala is the first IL-5 inhibitor to be approved for adult CRSwNP patients in the US

More: GSK’s Nucala approved to treat chronic rhinosinusitis with nasal polyps
Source: News